Medicare Enrolled

Dr. Carlos Buznego, M.D.

Ophthalmology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
8940 N KENDALL DR, Miami, FL 33176
3055982020
In practice since 2007 (18 years)
NPI: 1851512354 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Buznego from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buznego? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Buznego

Dr. Carlos Buznego is an ophthalmology in Miami, FL, with 18 years in practice. Based on federal Medicare data, Dr. Buznego performed 1,525 Medicare services across 1,303 unique beneficiaries.

Between the years covered by Open Payments, Dr. Buznego received a total of $285,148 from 62 pharmaceutical and/or device companies across 983 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Buznego is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 1,525 Medicare services$ $285,148 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,525
Medicare services
Bottom 37% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,303
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~85 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)368$99$199
Visual field test, extended240$48$102
Optic nerve imaging (OCT scan)220$26$100
Office visit, established patient (20-29 min)156$70$148
Corneal topography and eye depth measurement123$31$109
New patient office visit (45-59 min)117$116$250
Cataract surgery with lens implant91$446$2,100
Removal of recurring cataract in lens capsule using a laser63$276$406
Laser repair to improve eye fluid flow51$198$666
Comprehensive eye exam, established patient36$28$175
Ultrasound scan of cornea to determine thickness21$10$33
Eye exam, established patient, focused14$19$119
Exam of the internal drainage system of eye13$21$47
Retinal imaging (OCT scan)12$33$100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
16.6% medium
77.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$285,148
Total received (2018-2024)
Avg $40,735/year across 7 years
Top 3% in FL for ophthalmology
62
Companies
983
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$184,756 (64.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$79,077 (27.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,315 (7.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$31,297
2023
$18,057
2022
$27,583
2021
$47,715
2020
$27,450
2019
$87,113
2018
$45,933

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$71,847
Kala Pharmaceuticals, Inc.
$63,711
Sun Pharmaceutical Industries Inc.
$30,656
LENSAR, Inc.
$23,704
GLAUKOS CORPORATION
$18,508
Aerie Pharmaceuticals, Inc.
$18,021
Sight Sciences, Inc.
$14,384
Allergan Inc.
$5,249
Johnson & Johnson Surgical Vision, Inc.
$4,429
NEW WORLD MEDICAL,INC.
$3,471
Bausch & Lomb Americas Inc.
$3,158
Alcon Vision LLC
$2,766
ABBVIE INC.
$2,733
Horizon Therapeutics plc
$2,526
Bausch & Lomb, a division of Bausch Health US, LLC
$2,412
Allergan, Inc.
$1,989
Eyevance Pharmaceuticals LLC
$1,943
Alcon Research LLC
$1,750
Harrow Eye, LLC
$1,699
AbbVie Inc.
$1,455
Dompe US, Inc.
$904
SUN PHARMACEUTICAL INDUSTRIES INC.
$785
Oyster Point Pharma, Inc.
$694
Mallinckrodt Hospital Products Inc.
$658
Alcon Laboratories Inc
$630
Novartis Pharmaceuticals Corporation
$591
Regeneron Healthcare Solutions, Inc.
$587
Carl Zeiss Meditec, Inc.
$543
Tarsus Pharmaceuticals, Inc.
$365
Thea Pharma Inc.
$318
Rayner Intraocular Lenses Limited
$253
Apellis Pharmaceuticals, Inc.
$218
Shire North American Group Inc
$200
Carl Zeiss Meditec USA, Inc.
$184
Omeros Corporation
$175
Amgen Inc.
$154
Astellas Pharma US Inc
$143
BIOTISSUE HOLDINGS INC.
$132
Mallinckrodt Enterprises LLC
$113
Ivantis, Inc
$113
TISSUETECH, INC.
$87
Genentech USA, Inc.
$75
BioTissue Holdings, Inc.
$72
ANI Pharmaceuticals, Inc.
$70
BIOTISSUE HOLDINGS, INC.
$70
Ocular Therapeutix, Inc.
$65
NovaBay Pharmaceuticals, Inc.
$62
Merz Pharmaceuticals, LLC
$60
Beaver-Visitec International, Inc.
$48
TissueTech, Inc.
$47
Halozyme Inc
$46
Coherus Biosciences Inc.
$44
EyePoint Pharmaceuticals US, Inc.
$33
Immunocore Limited
$30
Dutch Ophthalmic, USA
$26
RxSight Inc
$25
EYEVANCE PHARMACEUTICALS LLC
$24
Merz North America, Inc.
$20
Akorn, Inc.
$19
Carl Zeiss Meditec AG
$19
Iridex Corporation
$18
Quidel Corporation
$14
Top 3 companies account for 58.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · Avenova · BEPREVE · BOTOX · BOTOX COSMETIC · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · CT Lucia · Centurion · Cequa · Cimerli · Clareon · DEXYCU · DOCTORS ALLERGY FORMULA · DURYSTA · EVA · EYLEA · EYLEA HD · EYSUVIS · Flarex · HYDRUS Microstent · HYLENEX RECOMBINANT · Hydrus · IACCESS · IHEEZO · INVELTYS · IOLMaster 500 · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · InflammaDry · Izervay · KIMMTRAK · Kahook Dual Blade · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OMIDRIA · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OPMI Lumera · ORA · OXERVATE · OZURDEX · Omidria · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · PanOptix · Prokera · QUATERA 700 · QULIPTA · RESTASIS · RESTASIS MULTIDOSE · RayOne EMV · ReSure Sealant · Rhopressa · STELLARIS · SURGICAL MISC · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Symfony IOL · Tobradex ST · UBRELVY · VEVYE · VISUDYNE · VUITY · VYZULTA · Vabysmo · Whitestart Phacoemulsficiation System · XDEMVY · XELPROS · XELPROS (latanoprost ophthalmic emulsion) 0.005% · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XEOMIN · XIIDRA · Xeomin · Zerviate · Zioptan · combined machine · enVista MX60 IOL · iDose · iDose TR · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent · iStent Trabecular Micro-Bypass Stent System · iStent Trabecular Micro-Bypass System Model iS3 · iStent infinite Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for ophthalmology in FL.

Equivalent to $18,698 per 100 Medicare services performed
Looking for a ophthalmology in Miami?
Compare ophthalmologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
274
Per 100K population
10.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Buznego is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Buznego experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Buznego performed 368 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Buznego receive payments from pharmaceutical companies?
Yes. Dr. Buznego received a total of $285,148 from 62 companies across 983 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buznego's costs compare to other ophthalmologys in Miami?
Dr. Buznego's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buznego) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →